<DOC>
	<DOC>NCT01476267</DOC>
	<brief_summary>This single center, open-label, non-randomized, one-treatment, one-period study will evaluate the metabolic profile and the safety of a single oral radiolabeled dose of dalcetrapib in male healthy volunteers.</brief_summary>
	<brief_title>A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dalcetrapib</mesh_term>
	<criteria>Healthy male subjects, 45 to 65 years of age inclusive Body mass index (BMI) between 18 and 32 kg/m2 inclusive Any concomitant disease or ongoing condition that in the investigator's opinion could interfere with the study or could pose an unacceptable risk to the subject Clinically significant abnormal laboratory values Infrequent bowel movements (e.g. less than one movement per 24 h on average) An intent to father children within 3 months of dosing Any external or internal radiotherapy with open (nuclear medicine) or sealed sources (brachy therapy) External irradiation (radiological examination) or internal radiation (diagnostic nuclear medicine procedure) within one year before study drug dosing; dental radiography and plain Xrays of the extremities are allowed before dosing</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>